메뉴 건너뛰기




Volumn 1, Issue 3, 2012, Pages 235-253

Nanomedicine: Pharmacological perspectives

Author keywords

Nanomedicine; Pharmacodynamics; Pharmacogenetics; Pharmacokinetics; Toxicity

Indexed keywords

MACHINERY; PHARMACODYNAMICS; PHARMACOKINETICS; TOXICITY;

EID: 84898923080     PISSN: 21919089     EISSN: 21919097     Source Type: Journal    
DOI: 10.1515/ntrev-2011-0010     Document Type: Article
Times cited : (18)

References (226)
  • 1
    • 33751419875 scopus 로고    scopus 로고
    • Nanomedicine: Developing smarter therapeutic and diagnostic modalities
    • Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev. 2006, 58, 1456-1459.
    • (2006) Adv. Drug Deliv. Rev , vol.58 , pp. 1456-1459
    • Farokhzad, O.C.1    Langer, R.2
  • 2
    • 34247475688 scopus 로고    scopus 로고
    • Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles
    • Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer 2007, 120, 2527-2537.
    • (2007) Int. J. Cancer , vol.120 , pp. 2527-2537
    • Liu, Y.1    Miyoshi, H.2    Nakamura, M.3
  • 3
    • 14644439267 scopus 로고    scopus 로고
    • Cancer nanotechnology: Opportunities and challenges
    • Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171.
    • (2005) Nat. Rev. Cancer , vol.5 , pp. 161-171
    • Ferrari, M.1
  • 4
    • 4444379133 scopus 로고    scopus 로고
    • Nanoparticle and targeted systems for cancer therapy
    • Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2004, 56, 1649-1659.
    • (2004) Adv. Drug Deliv. Rev , vol.56 , pp. 1649-1659
    • Brannon-Peppas, L.1    Blanchette, J.O.2
  • 5
    • 33646245291 scopus 로고    scopus 로고
    • Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer
    • Kawasaki ES, Player A. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine 2005, 1, 101-109.
    • (2005) Nanomedicine , vol.1 , pp. 101-109
    • Kawasaki, E.S.1    Player, A.2
  • 7
    • 0035253404 scopus 로고    scopus 로고
    • Drug-targeting strategies in cancer therapy
    • Huang PS, Oliff A. Drug-targeting strategies in cancer therapy. Curr. Opin. Genet. Dev. 2001, 11, 104-110.
    • (2001) Curr. Opin. Genet. Dev , vol.11 , pp. 104-110
    • Huang, P.S.1    Oliff, A.2
  • 8
    • 0344494508 scopus 로고    scopus 로고
    • Advancing the fi eld of drug delivery: Taking aim at cancer
    • Moses MA, Brem H, Langer R. Advancing the fi eld of drug delivery: taking aim at cancer. Cancer Cell 2003, 4, 337-341.
    • (2003) Cancer Cell , vol.4 , pp. 337-341
    • Moses, M.A.1    Brem, H.2    Langer, R.3
  • 9
    • 14044261316 scopus 로고    scopus 로고
    • What ' s wrong with our cancer models ?
    • Kamb A. What ' s wrong with our cancer models ? Nat. Rev. Drug Discov. 2005, 4, 161-165.
    • (2005) Nat. Rev. Drug Discov , vol.4 , pp. 161-165
    • Kamb, A.1
  • 10
    • 11144242211 scopus 로고    scopus 로고
    • Timeline: Chemotherapy and the war on cancer
    • Chabner BA, Roberts TG Jr. Timeline: chemotherapy and the war on cancer. Nat. Rev. Cancer 2005, 5, 65-72.
    • (2005) Nat. Rev. Cancer , vol.5 , pp. 65-72
    • Chabner, B.A.1    Roberts, T.G.2
  • 11
    • 0036629179 scopus 로고    scopus 로고
    • Nanostructures as tailored biological probes
    • Taton TA. Nanostructures as tailored biological probes. Trends Biotechnol. 2002, 20, 277-279.
    • (2002) Trends Biotechnol , vol.20 , pp. 277-279
    • Taton, T.A.1
  • 12
  • 14
    • 32544436574 scopus 로고    scopus 로고
    • Nano-oncology: Drug delivery, imaging, and sensing
    • Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 2006, 384, 620-630.
    • (2006) Anal. Bioanal. Chem , vol.384 , pp. 620-630
    • Portney, N.G.1    Ozkan, M.2
  • 15
    • 0038387390 scopus 로고    scopus 로고
    • The dawning era of polymer therapeutics
    • Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2003, 2, 347-360.
    • (2003) Nat. Rev. Drug Discov , vol.2 , pp. 347-360
    • Duncan, R.1
  • 16
    • 0032552819 scopus 로고    scopus 로고
    • Detection of functional groups and antibodies on microfabricated surfaces by confocal microscopy
    • Nashat AH, Moronne M, Ferrari M. Detection of functional groups and antibodies on microfabricated surfaces by confocal microscopy. Biotechnol. Bioeng. 1998, 60, 137-146.
    • (1998) Biotechnol. Bioeng , vol.60 , pp. 137-146
    • Nashat, A.H.1    Moronne, M.2    Ferrari, M.3
  • 17
    • 17144417434 scopus 로고    scopus 로고
    • A theoretical model for the margination of particles within blood vessels
    • Decuzzi P, Lee S, Bhushan B, Ferrari M. A theoretical model for the margination of particles within blood vessels. Ann. Biomed. Eng. 2005, 33, 179-190.
    • (2005) Ann. Biomed. Eng , vol.33 , pp. 179-190
    • Decuzzi, P.1    Lee, S.2    Bhushan, B.3    Ferrari, M.4
  • 18
    • 0028849284 scopus 로고
    • Time-dependent behavior of interstitial fl uid pressure in solid tumors: Implications for drug delivery
    • Netti PA, Baxter LT, Boucher Y, Skalak R, Jain RK. Time-dependent behavior of interstitial fl uid pressure in solid tumors: implications for drug delivery. Cancer Res. 1995, 55, 5451-5458.
    • (1995) Cancer Res , vol.55 , pp. 5451-5458
    • Netti, P.A.1    Baxter, L.T.2    Boucher, Y.3    Skalak, R.4    Jain, R.K.5
  • 19
    • 0036096806 scopus 로고    scopus 로고
    • Liposome-based drug delivery in breast cancer treatment
    • Park JW. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res. 2002, 4, 95-99.
    • (2002) Breast Cancer Res , vol.4 , pp. 95-99
    • Park, J.W.1
  • 20
    • 0025981079 scopus 로고
    • Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of lipo-somes depends on the liposome size and is unfavorable for immunoliposome binding to target
    • Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of lipo-somes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1991, 1062, 142-148.
    • (1991) Biochim. Biophys. Acta , vol.1062 , pp. 142-148
    • Klibanov, A.L.1    Maruyama, K.2    Beckerleg, A.M.3    Torchilin, V.P.4    Huang, L.5
  • 21
    • 0037184446 scopus 로고    scopus 로고
    • Designing macromolecules for therapeutic applications: Polyester dendrimer-poly(ethylene oxide) bow-tie hybrids with tunable molecular weight and architecture
    • Gillies ER, Frechet JMJ. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) bow-tie hybrids with tunable molecular weight and architecture. J. Am. Chem. Soc. 2002, 124, 14137-14146.
    • (2002) J. Am. Chem. Soc , vol.124 , pp. 14137-14146
    • Gillies, E.R.1    Frechet, J.M.J.2
  • 23
    • 63349090588 scopus 로고    scopus 로고
    • Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain
    • Denora N, Trapani A, Laquintana V, Lopedota A, Trapani G. Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain. Curr. Top. Med. Chem. 2009, 9, 182-196.
    • (2009) Curr. Top. Med. Chem , vol.9 , pp. 182-196
    • Denora, N.1    Trapani, A.2    Laquintana, V.3    Lopedota, A.4    Trapani, G.5
  • 24
    • 0346848865 scopus 로고    scopus 로고
    • Nanotech approaches to drug delivery and imaging
    • Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov. Today 2003, 8, 1112-1120.
    • (2003) Drug Discov. Today , vol.8 , pp. 1112-1120
    • Sahoo, S.K.1    Labhasetwar, V.2
  • 25
    • 12344262085 scopus 로고    scopus 로고
    • Drug transport to brain with targeted liposomes
    • Schnyder A, Huwyler J. Drug transport to brain with targeted liposomes. NeuroRx 2005, 2, 99-107.
    • (2005) NeuroRx , vol.2 , pp. 99-107
    • Schnyder, A.1    Huwyler, J.2
  • 26
    • 14144250911 scopus 로고    scopus 로고
    • Recent advances with liposomes as pharmaceutical carriers
    • Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4, 145-160.
    • (2005) Nat. Rev. Drug Discov , vol.4 , pp. 145-160
    • Torchilin, V.P.1
  • 27
    • 0141927263 scopus 로고    scopus 로고
    • Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties
    • Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42, 463-478.
    • (2003) Prog. Lipid Res , vol.42 , pp. 463-478
    • Moghimi, S.M.1    Szebeni, J.2
  • 28
    • 77955466238 scopus 로고    scopus 로고
    • Nanoparticle-mediated brain-specifi c drug delivery, imaging, and diagnosis
    • Yang H. Nanoparticle-mediated brain-specifi c drug delivery, imaging, and diagnosis. Pharm. Res. 2010, 27, 1759-1771.
    • (2010) Pharm. Res , vol.27 , pp. 1759-1771
    • Yang, H.1
  • 30
    • 0034992134 scopus 로고    scopus 로고
    • Trends and developments in liposome drug delivery systems
    • Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 2001, 90, 667-680.
    • (2001) J. Pharm. Sci , vol.90 , pp. 667-680
    • Lian, T.1    Ho, R.J.2
  • 31
    • 0028222291 scopus 로고
    • Long-circulating (sterically stabilized) liposomes for targeted drug delivery
    • Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 1994, 15, 215-220.
    • (1994) Trends Pharmacol. Sci , vol.15 , pp. 215-220
    • Allen, T.M.1
  • 32
  • 33
    • 69249217640 scopus 로고    scopus 로고
    • Biomaterials for promoting brain protection, repair and regeneration
    • Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, repair and regeneration. Nat. Rev. Neurosci. 2009, 10, 682-692.
    • (2009) Nat. Rev. Neurosci , vol.10 , pp. 682-692
    • Orive, G.1    Anitua, E.2    Pedraz, J.L.3    Emerich, D.F.4
  • 35
    • 34248672837 scopus 로고    scopus 로고
    • Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specifi city
    • Akhtar S, Benter I. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specifi city. Adv. Drug Deliv. Rev. 2007, 59, 164-182.
    • (2007) Adv. Drug Deliv. Rev , vol.59 , pp. 164-182
    • Akhtar, S.1    Benter, I.2
  • 37
    • 80054756400 scopus 로고    scopus 로고
    • Multistage nanovectors: From concept to novel imaging contrast agents and therapeutics
    • Godin B, Tasciotti E, Liu X, Serda RE, Ferrari M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc. Chem. Res. 2011, 44, 979-989.
    • (2011) Acc. Chem. Res , vol.44 , pp. 979-989
    • Godin, B.1    Tasciotti, E.2    Liu, X.3    Serda, R.E.4    Ferrari, M.5
  • 44
    • 77955480347 scopus 로고    scopus 로고
    • Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes
    • Yasuzaki Y, Yamada Y, Harashima H. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem. Biophys. Res. Commun. 2010, 397, 181-186.
    • (2010) Biochem. Biophys. Res. Commun , vol.397 , pp. 181-186
    • Yasuzaki, Y.1    Yamada, Y.2    Harashima, H.3
  • 45
    • 79961023252 scopus 로고    scopus 로고
    • Dual function MITO-Porter, a nanocarrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery
    • Yamada Y, Furukawa R, Yasuzaki Y, Harashima H. Dual function MITO-Porter, a nanocarrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol. Ther. 2011, 19, 1449-1456.
    • (2011) Mol. Ther , vol.19 , pp. 1449-1456
    • Yamada, Y.1    Furukawa, R.2    Yasuzaki, Y.3    Harashima, H.4
  • 46
    • 83555164614 scopus 로고    scopus 로고
    • Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter
    • Yamada Y, Harashima H. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter. Biomaterials 2012, 33, 1589-1595.
    • (2012) Biomaterials , vol.33 , pp. 1589-1595
    • Yamada, Y.1    Harashima, H.2
  • 47
    • 0028310282 scopus 로고
    • Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism
    • McRae A, Dahlstrom A. Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism. Neurochem. Int. 1994, 25, 27-33.
    • (1994) Neurochem. Int , vol.25 , pp. 27-33
    • McRae, A.1    Dahlstrom, A.2
  • 48
    • 0035946615 scopus 로고    scopus 로고
    • Solid lipid nanoparticles: Production, characterization and applications
    • Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 47, 165-196.
    • (2001) Adv. Drug Deliv. Rev , vol.47 , pp. 165-196
    • Mehnert, W.1    Mader, K.2
  • 50
    • 41449091856 scopus 로고    scopus 로고
    • Potential of solid lipid nanoparticles in brain targeting
    • Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J. Control. Rel. 2008, 127, 97-109.
    • (2008) J. Control. Rel , vol.127 , pp. 97-109
    • Kaur, I.P.1    Bhandari, R.2    Bhandari, S.3    Kakkar, V.4
  • 51
    • 34249079979 scopus 로고    scopus 로고
    • Solid lipid nanoparticles: Could they help to improve the efficacy of pharmacologic treatments for brain tumors ?
    • Brioschi A, Zenga F, Zara GP, Gasco MR, Ducati A, Mauro A. Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors ? Neurol. Res. 2007, 29, 324-330.
    • (2007) Neurol. Res , vol.29 , pp. 324-330
    • Brioschi, A.1    Zenga, F.2    Zara, G.P.3    Gasco, M.R.4    Ducati, A.5    Mauro, A.6
  • 52
    • 51749096415 scopus 로고    scopus 로고
    • Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line
    • Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm. Res. 2008, 25, 2262-2271.
    • (2008) Pharm. Res , vol.25 , pp. 2262-2271
    • Chattopadhyay, N.1    Zastre, J.2    Wong, H.L.3    Wu, X.Y.4    Bendayan, R.5
  • 53
    • 51049101925 scopus 로고    scopus 로고
    • Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA
    • Kim HR, Kim IK, Bae KH, Lee SH, Lee Y, Park TG. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol. Pharm. 2008, 5, 622-631.
    • (2008) Mol. Pharm , vol.5 , pp. 622-631
    • Kim, H.R.1    Kim, I.K.2    Bae, K.H.3    Lee, S.H.4    Lee, Y.5    Park, T.G.6
  • 57
    • 0036205158 scopus 로고    scopus 로고
    • Nanoparticle technology for drug delivery across the blood-brain barrier
    • Lockman PR, Mumper RJ, Khan MA, Allen DD. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 2002, 28, 1-13.
    • (2002) Drug Dev. Ind. Pharm , vol.28 , pp. 1-13
    • Lockman, P.R.1    Mumper, R.J.2    Khan, M.A.3    Allen, D.D.4
  • 58
    • 47649114017 scopus 로고    scopus 로고
    • Biomaterials for the central nervous system
    • Zhong Y, Bellamkonda RV. Biomaterials for the central nervous system. J. R. Soc. Interface 2008, 5, 957-975.
    • (2008) J. R. Soc. Interface , vol.5 , pp. 957-975
    • Zhong, Y.1    Bellamkonda, R.V.2
  • 60
    • 0037335187 scopus 로고    scopus 로고
    • Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specifi c mechanisms requiring prior binding of drug to the nanoparticles
    • Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, von Briesen H, Begley DJ. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specifi c mechanisms requiring prior binding of drug to the nanoparticles. Pharm. Res. 2003, 20, 409-416.
    • (2003) Pharm. Res , vol.20 , pp. 409-416
    • Kreuter, J.1    Ramge, P.2    Petrov, V.3    Hamm, S.4    Gelperina, S.E.5    Engelhardt, B.6    Alyautdin, R.7    Von Briesen, H.8    Begley, D.J.9
  • 62
    • 48449094740 scopus 로고    scopus 로고
    • Poly(lacticco-glycolic acid) nanospheres and microspheres for short-and long-term delivery of bioactive ciliary neurotrophic factor
    • Nkansah MK, Tzeng SY, Holdt AM, Lavik EB. Poly(lacticco-glycolic acid) nanospheres and microspheres for short-and long-term delivery of bioactive ciliary neurotrophic factor. Biotechnol. Bioeng. 2008, 100, 1010-1019.
    • (2008) Biotechnol. Bioeng , vol.100 , pp. 1010-1019
    • Nkansah, M.K.1    Tzeng, S.Y.2    Holdt, A.M.3    Lavik, E.B.4
  • 63
    • 84856755816 scopus 로고    scopus 로고
    • Pilocarpineloaded poly(DL-lactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response
    • Nair KL, Vidyanand S, James J, Kumar GSV. Pilocarpineloaded poly(DL-lactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response. J. Appl. Polym. Sci. 2012, 124, 2030-2036.
    • (2012) J. Appl. Polym. Sci , vol.124 , pp. 2030-2036
    • Nair, K.L.1    Vidyanand, S.2    James, J.3    Kumar, G.S.V.4
  • 64
    • 0021349643 scopus 로고
    • Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image
    • Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res. 1984, 44, 2115-2121.
    • (1984) Cancer Res , vol.44 , pp. 2115-2121
    • Iwai, K.1    Maeda, H.2    Konno, T.3
  • 65
    • 0022858683 scopus 로고
    • A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumori-tropic accumulation of proteins and the antitumor agent SMANCs
    • Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumori-tropic accumulation of proteins and the antitumor agent SMANCs. Cancer Res. 1986, 46, 6387-6392.
    • (1986) Cancer Res , vol.46 , pp. 6387-6392
    • Matsumura, Y.1    Maeda, H.2
  • 66
    • 0037124546 scopus 로고    scopus 로고
    • The origin of pegnology
    • Davis FF. The origin of pegnology. Adv. Drug Deliv. Rev. 2002, 54, 457-458.
    • (2002) Adv. Drug Deliv. Rev , vol.54 , pp. 457-458
    • Davis, F.F.1
  • 67
    • 0025028357 scopus 로고
    • Efficacy of once-a-day terazosin in benign prostatic hyperplasia: A randomized, double-blind placebo-controlled clinical trial
    • Fabricius PG, Weizert P, Dunzendorfer U, Hannaford JM, Maurath C. Efficacy of once-a-day terazosin in benign prostatic hyperplasia: a randomized, double-blind placebo-controlled clinical trial. Prostate Suppl. 1990, 3, 85-93.
    • (1990) Prostate Suppl , vol.3 , pp. 85-93
    • Fabricius, P.G.1    Weizert, P.2    Dunzendorfer, U.3    Hannaford, J.M.4    Maurath, C.5
  • 68
    • 0042999388 scopus 로고    scopus 로고
    • Pegaspargase: A review of clinical studies
    • Graham ML. Pegaspargase: a review of clinical studies. Adv. Drug Deliv. Rev. 2003, 55, 1293-1302.
    • (2003) Adv. Drug Deliv. Rev , vol.55 , pp. 1293-1302
    • Graham, M.L.1
  • 69
    • 0029160083 scopus 로고
    • Lezoualc ' h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
    • Boussif O, Lezoualc ' h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 1995, 92, 7297-7301.
    • (1995) Proc. Natl. Acad. Sci. USA , vol.92 , pp. 7297-7301
    • Boussif, O.1
  • 70
    • 33744805790 scopus 로고    scopus 로고
    • Polymers for gene delivery across length scales
    • Putnam D. Polymers for gene delivery across length scales. Nat. Mater. 2006, 5, 439-451.
    • (2006) Nat. Mater , vol.5 , pp. 439-451
    • Putnam, D.1
  • 72
    • 47749100430 scopus 로고    scopus 로고
    • Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity
    • Zintchenko A, Philipp A, Dehshahri A, Wagner E. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconj. Chem. 2008, 19, 1448-1455.
    • (2008) Bioconj. Chem , vol.19 , pp. 1448-1455
    • Zintchenko, A.1    Philipp, A.2    Dehshahri, A.3    Wagner, E.4
  • 73
    • 12344291244 scopus 로고    scopus 로고
    • Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers
    • Zhu J, Tang A, Law LP, Feng M, Ho KM, Lee DK, Harris FW, Li P. Amphiphilic core-shell nanoparticles with poly(ethylenimine) shells as potential gene delivery carriers. Bioconj. Chem. 2005, 16, 139-146.
    • (2005) Bioconj. Chem , vol.16 , pp. 139-146
    • Zhu, J.1    Tang, A.2    Law, L.P.3    Feng, M.4    Ho, K.M.5    Lee, D.K.6    Harris, F.W.7    Li, P.8
  • 74
    • 77951159570 scopus 로고    scopus 로고
    • The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro
    • Wu Y, Wang W, Chen Y, Huang K, Shuai X, Chen Q, Li X, Lian G. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro. Int. J. Nanomed. 2010, 5, 129-136.
    • (2010) Int. J. Nanomed , vol.5 , pp. 129-136
    • Wu, Y.1    Wang, W.2    Chen, Y.3    Huang, K.4    Shuai, X.5    Chen, Q.6    Li, X.7    Lian, G.8
  • 75
    • 84857917025 scopus 로고    scopus 로고
    • Polyethyleneimine-based core-shell nanogels: A promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells
    • Mimi H, Ho KM, Siu YS, Wu A, Li P. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells. J. Control. Rel. 2012, 158, 123-130.
    • (2012) J. Control. Rel , vol.158 , pp. 123-130
    • Mimi, H.1    Ho, K.M.2    Siu, Y.S.3    Wu, A.4    Li, P.5
  • 77
    • 67649229657 scopus 로고    scopus 로고
    • Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers
    • Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv. Drug Deliv. Rev. 2009, 61, 768-784.
    • (2009) Adv. Drug Deliv. Rev , vol.61 , pp. 768-784
    • Bae, Y.1    Kataoka, K.2
  • 78
    • 34250770499 scopus 로고    scopus 로고
    • Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation
    • Akagi D, Oba M, Koyama H, Nishiyama N, Fukushima S, Miyata T, Nagawa H, Kataoka K. Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation. Gene Ther. 2007, 14, 1029-1038.
    • (2007) Gene Ther , vol.14 , pp. 1029-1038
    • Akagi, D.1    Oba, M.2    Koyama, H.3    Nishiyama, N.4    Fukushima, S.5    Miyata, T.6    Nagawa, H.7    Kataoka, K.8
  • 79
    • 33845388144 scopus 로고    scopus 로고
    • Micellar nanocarriers: Pharmaceutical perspectives
    • Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 2007, 24, 1-16.
    • (2007) Pharm. Res , vol.24 , pp. 1-16
    • Torchilin, V.P.1
  • 80
    • 0035080570 scopus 로고    scopus 로고
    • Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers
    • Harada A, Togawa H, Kataoka K. Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. Eur. J. Pharm. Sci. 2001, 13, 35-42.
    • (2001) Eur. J. Pharm. Sci , vol.13 , pp. 35-42
    • Harada, A.1    Togawa, H.2    Kataoka, K.3
  • 85
    • 0037338049 scopus 로고    scopus 로고
    • Liposomemediated targeting of enzymes to cancer cells for site-specifi c activation of prodrugs: Comparison with the corresponding antibody-enzyme conjugate
    • Fonseca MJ, Jagtenberg JC, Haisma HJ, Storm G. Liposomemediated targeting of enzymes to cancer cells for site-specifi c activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate. Pharm. Res. 2003, 20, 423-428.
    • (2003) Pharm. Res , vol.20 , pp. 423-428
    • Fonseca, M.J.1    Jagtenberg, J.C.2    Haisma, H.J.3    Storm, G.4
  • 87
    • 0037151313 scopus 로고    scopus 로고
    • Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery
    • Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Rel. 2002, 82, 189-212.
    • (2002) J. Control. Rel , vol.82 , pp. 189-212
    • Kabanov, A.V.1    Batrakova, E.V.2    Alakhov, V.Y.3
  • 88
    • 85047695467 scopus 로고    scopus 로고
    • Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer
    • Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K. Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther. 2002, 9, 407-414.
    • (2002) Gene Ther , vol.9 , pp. 407-414
    • Harada-Shiba, M.1    Yamauchi, K.2    Harada, A.3    Takamisawa, I.4    Shimokado, K.5    Kataoka, K.6
  • 94
    • 38549180565 scopus 로고    scopus 로고
    • Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier
    • Liu L, Guo K, Lu J, Venkatraman SS, Luo D, Ng KC, Ling EA, Moochhala S, Yang YY. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 2008, 29, 1509-1517.
    • (2008) Biomaterials , vol.29 , pp. 1509-1517
    • Liu, L.1    Guo, K.2    Lu, J.3    Venkatraman, S.S.4    Luo, D.5    Ng, K.C.6    Ling, E.A.7    Moochhala, S.8    Yang, Y.Y.9
  • 96
    • 0030460361 scopus 로고    scopus 로고
    • Chemotherapy in the management of patients with inoperable non-small cell lung cancer
    • Carney DN. Chemotherapy in the management of patients with inoperable non-small cell lung cancer. Semin. Oncol. 1996, 23(Suppl. 16), 71-75.
    • (1996) Semin. Oncol , vol.23 , pp. 71-75
    • Carney, D.N.1
  • 97
    • 0034177397 scopus 로고    scopus 로고
    • The taxanes: An update
    • Crown J, O ' Leary M. The taxanes: an update. Lancet 2000, 355, 1176-1178.
    • (2000) Lancet , vol.355 , pp. 1176-1178
    • Crown, J.1    O'Leary, M.2
  • 101
    • 1042302105 scopus 로고    scopus 로고
    • Dendrimers and protein cages as nanoparticles in drug delivery
    • Cloninger M. Dendrimers and protein cages as nanoparticles in drug delivery. Drug Discov. Today 2004, 9, 111-112.
    • (2004) Drug Discov. Today , vol.9 , pp. 111-112
    • Cloninger, M.1
  • 102
    • 0036899037 scopus 로고    scopus 로고
    • Biological applications of dendrimers
    • Cloninger MJ. Biological applications of dendrimers. Curr. Opin. Chem. Biol. 2002, 6, 742-748.
    • (2002) Curr. Opin. Chem. Biol , vol.6 , pp. 742-748
    • Cloninger, M.J.1
  • 103
    • 0033792661 scopus 로고    scopus 로고
    • Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle
    • Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. Mol. Pharmacol. 2000, 58, 1100-1108.
    • (2000) Mol. Pharmacol , vol.58 , pp. 1100-1108
    • Witvrouw, M.1    Fikkert, V.2    Pluymers, W.3    Matthews, B.4    Mardel, K.5    Schols, D.6    Raff, J.7    Debyser, Z.8    De Clercq, E.9    Holan, G.10    Pannecouque, C.11
  • 105
    • 24944531237 scopus 로고    scopus 로고
    • Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy
    • Majoros IJ, Thomas TP, Mehta CB, Baker Jr. J.R. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 2005, 48, 5892-5899.
    • (2005) J. Med. Chem , vol.48 , pp. 5892-5899
    • Majoros, I.J.1    Thomas, T.P.2    Mehta, C.B.3    Baker, J.R.4
  • 107
    • 33644593095 scopus 로고    scopus 로고
    • PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality
    • Majoros IJ, Myc A, Thomas T, Mehta CB, Baker Jr. J.R. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 2006, 7, 572-579.
    • (2006) Biomacromolecules , vol.7 , pp. 572-579
    • Majoros, I.J.1    Myc, A.2    Thomas, T.3    Mehta, C.B.4    Baker, J.R.5
  • 108
    • 29744458148 scopus 로고    scopus 로고
    • Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates
    • Shukla R, Thomas TP, Peters J, Kotlyar A, Myc A, Baker Jr. J.R. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Chem. Commun. 2005, 46, 5739-5741.
    • (2005) Chem. Commun , vol.46 , pp. 5739-5741
    • Shukla, R.1    Thomas, T.P.2    Peters, J.3    Kotlyar, A.4    Myc, A.5    Baker, J.R.6
  • 109
    • 0038714289 scopus 로고    scopus 로고
    • Endothelial signaling during development
    • Cleaver O, Melton DA. Endothelial signaling during development. Nat. Med. 2003, 9, 661-668.
    • (2003) Nat. Med , vol.9 , pp. 661-668
    • Cleaver, O.1    Melton, D.A.2
  • 110
    • 20344394447 scopus 로고    scopus 로고
    • Boron neutron capture therapy of cancer: Current status and future prospects
    • Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 2005, 11, 3987-4002.
    • (2005) Clin. Cancer Res , vol.11 , pp. 3987-4002
    • Barth, R.F.1    Coderre, J.A.2    Vicente, M.G.3    Blue, T.E.4
  • 112
    • 0027950222 scopus 로고
    • Boronated starburst dendrimer monoclonal-antibody immu-noconjugates-evaluation as a potential delivery system for neutron-capture therapy
    • Barth RF, Adams DM, Soloway AH, Alam F, Darby MV. Boronated starburst dendrimer monoclonal-antibody immu-noconjugates-evaluation as a potential delivery system for neutron-capture therapy. Bioconj. Chem. 1994, 5, 58-66.
    • (1994) Bioconj. Chem , vol.5 , pp. 58-66
    • Barth, R.F.1    Adams, D.M.2    Soloway, A.H.3    Alam, F.4    Darby, M.V.5
  • 113
    • 0842285204 scopus 로고    scopus 로고
    • Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy
    • Wu G, Barth RF, Yang WL, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconj. Chem. 2004, 15, 185-194.
    • (2004) Bioconj. Chem , vol.15 , pp. 185-194
    • Wu, G.1    Barth, R.F.2    Yang, W.L.3    Chatterjee, M.4    Tjarks, W.5    Ciesielski, M.J.6    Fenstermaker, R.A.7
  • 115
    • 33750010294 scopus 로고    scopus 로고
    • Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory defi cits induced by scopolamine in mice
    • Xie YL, Lu W, Jiang XG. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory defi cits induced by scopolamine in mice. Behav. Brain Res. 2006, 173, 76-84.
    • (2006) Behav. Brain Res , vol.173 , pp. 76-84
    • Xie, Y.L.1    Lu, W.2    Jiang, X.G.3
  • 116
    • 33947143588 scopus 로고    scopus 로고
    • Surfactant-polymer nanoparticles: A novel platform for sustained and enhanced cellular delivery of water-soluble molecules
    • Chavanpatil MD, Khdair A, Panyam J. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm. Res. 2007, 24, 803-810.
    • (2007) Pharm. Res , vol.24 , pp. 803-810
    • Chavanpatil, M.D.1    Khdair, A.2    Panyam, J.3
  • 117
    • 24044459756 scopus 로고    scopus 로고
    • Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity
    • Hyung Park J, Kwon S, Lee M, Chung H, Kim JH, Kim YS, Park RW, Kim IS, Bong Seo S, Kwon IC, Young Jeong S. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials 2006, 27, 119-126.
    • (2006) Biomaterials , vol.27 , pp. 119-126
    • Hyung Park, J.1    Kwon, S.2    Lee, M.3    Chung, H.4    Kim, J.H.5    Kim, Y.S.6    Park, R.W.7    Kim, I.S.8    Bong Seo, S.9    Kwon, I.C.10    Young Jeong, S.11
  • 121
    • 0038202316 scopus 로고    scopus 로고
    • Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy
    • Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc. 2003, 125, 7860-7865.
    • (2003) J. Am. Chem. Soc , vol.125 , pp. 7860-7865
    • Roy, I.1    Ohulchanskyy, T.Y.2    Pudavar, H.E.3    Bergey, E.J.4    Oseroff, A.R.5    Morgan, J.6    Dougherty, T.J.7    Prasad, P.N.8
  • 122
    • 33646594749 scopus 로고    scopus 로고
    • A new class of silica cross-linked micellar core-shell nanoparticles
    • Huo Q, Liu J, Wang LQ, Jiang Y, Lambert TN, Fang E. A new class of silica cross-linked micellar core-shell nanoparticles. J. Am. Chem. Soc. 2006, 128, 6447-6453.
    • (2006) J. Am. Chem. Soc , vol.128 , pp. 6447-6453
    • Huo, Q.1    Liu, J.2    Wang, L.Q.3    Jiang, Y.4    Lambert, T.N.5    Fang, E.6
  • 125
    • 0342819025 scopus 로고
    • Helical microtubules of graphitic carbon
    • Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354, 56-58.
    • (1991) Nature , vol.354 , pp. 56-58
    • Iijima, S.1
  • 126
    • 1642540193 scopus 로고    scopus 로고
    • Translocation of bioactive peptides across cell membranes by carbon nanotubes
    • Pantarotto D, Briand JP, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 2004, 1, 16-17.
    • (2004) Chem. Commun , vol.1 , pp. 16-17
    • Pantarotto, D.1    Briand, J.P.2    Prato, M.3    Bianco, A.4
  • 128
  • 129
    • 50249159611 scopus 로고    scopus 로고
    • Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device
    • Dhar S, Liu Z, Thomale J, Dai HJ, Lippard SJ. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J. Am. Chem. Soc. 2008, 130, 11467-11476.
    • (2008) J. Am. Chem. Soc , vol.130 , pp. 11467-11476
    • Dhar, S.1    Liu, Z.2    Thomale, J.3    Dai, H.J.4    Lippard, S.J.5
  • 130
    • 57549085002 scopus 로고    scopus 로고
    • Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery
    • Chen J, Chen S, Zhao X, Kuznetsova LV, Wong SS, Ojima I. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J. Am. Chem. Soc. 2008, 130, 16778-16785.
    • (2008) J. Am. Chem. Soc , vol.130 , pp. 16778-16785
    • Chen, J.1    Chen, S.2    Zhao, X.3    Kuznetsova, L.V.4    Wong, S.S.5    Ojima, I.6
  • 132
    • 33748601861 scopus 로고    scopus 로고
    • Biomedical applications and potential health risks of nanomaterials: Molecular mechanisms
    • Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr. Mol. Med. 2006, 6, 651-663.
    • (2006) Curr. Mol. Med , vol.6 , pp. 651-663
    • Lanone, S.1    Boczkowski, J.2
  • 134
    • 34547690726 scopus 로고    scopus 로고
    • Immunological properties of engineered nanomaterials
    • Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2, 469-478.
    • (2007) Nat. Nanotechnol , vol.2 , pp. 469-478
    • Dobrovolskaia, M.A.1    McNeil, S.E.2
  • 135
    • 38049162212 scopus 로고    scopus 로고
    • Engineered nanomaterials in soils and water: How do they behave and could they pose a risk to human health ?
    • Boxall AB, Tiede K, Chaudhry Q. Engineered nanomaterials in soils and water: how do they behave and could they pose a risk to human health ? Nanomedicine 2007, 2, 919-927.
    • (2007) Nanomedicine , vol.2 , pp. 919-927
    • Boxall, A.B.1    Tiede, K.2    Chaudhry, Q.3
  • 136
    • 31944451232 scopus 로고    scopus 로고
    • Toxic potential of materials at the nanolevel
    • Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006, 311, 622-627.
    • (2006) Science , vol.311 , pp. 622-627
    • Nel, A.1    Xia, T.2    Madler, L.3    Li, N.4
  • 137
    • 79951712963 scopus 로고    scopus 로고
    • Perspectives in nanomedicine-based research towards cancer therapies
    • Rane YM, Souto EB. Perspectives in nanomedicine-based research towards cancer therapies. Curr. Nanosci. 2011, 7, 142-152.
    • (2011) Curr. Nanosci , vol.7 , pp. 142-152
    • Rane, Y.M.1    Souto, E.B.2
  • 138
    • 80055084025 scopus 로고    scopus 로고
    • Food packaging based on polymer nanomaterials
    • Silvestre C, Duraccio D, Cimmino S. Food packaging based on polymer nanomaterials. Prog. Polym. Sci. 2011, 36, 1766-1782.
    • (2011) Prog. Polym. Sci , vol.36 , pp. 1766-1782
    • Silvestre, C.1    Duraccio, D.2    Cimmino, S.3
  • 139
    • 78651240699 scopus 로고    scopus 로고
    • Nanotechnology and in situ remediation: A review of the benefi ts and potential risks
    • Karn B, Kuiken T, Otto M. Nanotechnology and in situ remediation: a review of the benefi ts and potential risks. Cien Saude Colet. 2011, 16, 165-178.
    • (2011) Cien Saude Colet , vol.16 , pp. 165-178
    • Karn, B.1    Kuiken, T.2    Otto, M.3
  • 140
    • 78650783860 scopus 로고    scopus 로고
    • Fate and transport of engineered nanomaterials in the environment
    • Lin D, Tian X, Wu F, Xing B. Fate and transport of engineered nanomaterials in the environment. J. Environ. Qual. 2010, 39, 1896-1908.
    • (2010) J. Environ. Qual , vol.39 , pp. 1896-1908
    • Lin, D.1    Tian, X.2    Wu, F.3    Xing, B.4
  • 141
    • 77949917110 scopus 로고    scopus 로고
    • Potential hazard of nanoparticles: From properties to biological and environmental effects
    • Kahru A, Savolainen K. Potential hazard of nanoparticles: from properties to biological and environmental effects. Toxicology 2010, 269, 89-91.
    • (2010) Toxicology , vol.269 , pp. 89-91
    • Kahru, A.1    Savolainen, K.2
  • 143
    • 68649099669 scopus 로고    scopus 로고
    • Analysis, behavior and ecotoxicity of carbon-based nanomaterials in the aquatic environment
    • Perez S, Farre M, Barcelo D. Analysis, behavior and ecotoxicity of carbon-based nanomaterials in the aquatic environment. Trends Anal. Chem. 2009, 28, 820-832.
    • (2009) Trends Anal. Chem , vol.28 , pp. 820-832
    • Perez, S.1    Farre, M.2    Barcelo, D.3
  • 144
    • 61349139614 scopus 로고    scopus 로고
    • Drug delivery and nanoparticles: Applications and hazards
    • De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3, 133-149.
    • (2008) Int. J. Nanomed , vol.3 , pp. 133-149
    • De Jong, W.H.1    Borm, P.J.2
  • 145
    • 33645744010 scopus 로고    scopus 로고
    • A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks
    • Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 2006, 36, 189-217.
    • (2006) Crit. Rev. Toxicol , vol.36 , pp. 189-217
    • Lam, C.W.1    James, J.T.2    McCluskey, R.3    Arepalli, S.4    Hunter, R.L.5
  • 146
    • 1542726626 scopus 로고    scopus 로고
    • Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation
    • Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 2004, 77, 126-134.
    • (2004) Toxicol. Sci , vol.77 , pp. 126-134
    • Lam, C.W.1    James, J.T.2    McCluskey, R.3    Hunter, R.L.4
  • 147
    • 25844464705 scopus 로고    scopus 로고
    • Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappa B in human keratinocytes
    • Manna SK, Sarkar S, Barr J, Wise K, Barrera EV, Jejelowo O, Rice-Ficht AC, Ramesh GT. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappa B in human keratinocytes. Nano Lett. 2005, 5, 1676-1684.
    • (2005) Nano Lett , vol.5 , pp. 1676-1684
    • Manna, S.K.1    Sarkar, S.2    Barr, J.3    Wise, K.4    Barrera, E.V.5    Jejelowo, O.6    Rice-Ficht, A.C.7    Ramesh, G.T.8
  • 152
    • 33645674888 scopus 로고    scopus 로고
    • Solubilization, purification and functionalization of carbon nanotubes using polyoxometalate
    • Fei B, Lu HF, Hu ZG, Xin JH. Solubilization, purification and functionalization of carbon nanotubes using polyoxometalate. Nanotechnology 2006, 17, 1589-1593.
    • (2006) Nanotechnology , vol.17 , pp. 1589-1593
    • Fei, B.1    Lu, H.F.2    Hu, Z.G.3    Xin, J.H.4
  • 153
    • 84859727420 scopus 로고    scopus 로고
    • DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis
    • Bhattacharya S, Roxbury D, Gong X, Mukhopadhyay D, Jagota A. DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. Nano Lett. 2012, 12, 1826-1830.
    • (2012) Nano Lett , vol.12 , pp. 1826-1830
    • Bhattacharya, S.1    Roxbury, D.2    Gong, X.3    Mukhopadhyay, D.4    Jagota, A.5
  • 154
    • 33745741441 scopus 로고    scopus 로고
    • Oops they did it again! Carbon nanotubes hoax scientists in viability assays
    • Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006, 6, 1261-1268.
    • (2006) Nano Lett , vol.6 , pp. 1261-1268
    • Worle-Knirsch, J.M.1    Pulskamp, K.2    Krug, H.F.3
  • 155
    • 60049097217 scopus 로고    scopus 로고
    • Aggregation and disaggregation of iron oxide nanoparticles: influence of particle concentration, pH and natural organic matter
    • Baalousha M. Aggregation and disaggregation of iron oxide nanoparticles: influence of particle concentration, pH and natural organic matter. Sci. Total Environ. 2009, 407, 2093-2101.
    • (2009) Sci. Total Environ , vol.407 , pp. 2093-2101
    • Baalousha, M.1
  • 156
    • 33947360667 scopus 로고    scopus 로고
    • In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line
    • Chang JS, Chang KL, Hwang DF, Kong ZL. In vitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 2007, 41, 2064-2068.
    • (2007) Environ. Sci. Technol , vol.41 , pp. 2064-2068
    • Chang, J.S.1    Chang, K.L.2    Hwang, D.F.3    Kong, Z.L.4
  • 158
    • 0025253906 scopus 로고
    • Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging
    • Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990, 175, 494-498.
    • (1990) Radiology , vol.175 , pp. 494-498
    • Weissleder, R.1    Elizondo, G.2    Wittenberg, J.3    Lee, A.S.4    Josephson, L.5    Brady, T.J.6
  • 159
    • 32044451341 scopus 로고    scopus 로고
    • Toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors
    • Hardman RA. Toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 2006, 114, 165-172.
    • (2006) Environ. Health Perspect , vol.114 , pp. 165-172
    • Hardman, R.A.1
  • 160
    • 23044459574 scopus 로고    scopus 로고
    • Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots
    • Lovric J, Bazzi HS, Cuie Y, Fortin GRA, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J. Mol. Med. 2005, 83, 377-385.
    • (2005) J. Mol. Med , vol.83 , pp. 377-385
    • Lovric, J.1    Bazzi, H.S.2    Cuie, Y.3    Fortin, G.R.A.4    Winnik, F.M.5    Maysinger, D.6
  • 162
    • 0029789793 scopus 로고    scopus 로고
    • Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
    • Plank C, Mechtler K, Szoka FC Jr, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 1996, 7, 1437-1446.
    • (1996) Hum. Gene Ther , vol.7 , pp. 1437-1446
    • Plank, C.1    Mechtler, K.2    Szoka, F.C.3    Wagner, E.4
  • 164
    • 28744445460 scopus 로고    scopus 로고
    • Dendrimer biocompatibility and toxicity
    • Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 2005, 57, 2215-2237.
    • (2005) Adv. Drug Deliv. Rev , vol.57 , pp. 2215-2237
    • Duncan, R.1    Izzo, L.2
  • 165
    • 46449100402 scopus 로고    scopus 로고
    • The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers
    • Kaminskas LM, Boyd BJ, Karellas P, Krippner GY, Lessene R, Kelly B, Porter CJ. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. Mol. Pharm. 2008, 5, 449-463.
    • (2008) Mol. Pharm , vol.5 , pp. 449-463
    • Kaminskas, L.M.1    Boyd, B.J.2    Karellas, P.3    Krippner, G.Y.4    Lessene, R.5    Kelly, B.6    Porter, C.J.7
  • 167
    • 0035999704 scopus 로고    scopus 로고
    • Polyester dendritic systems for drug delivery applications: In vitro and in vivo evaluation
    • Padilla De Jesus OL, Ihre HR, Gagne L, Frechet JM, Szoka FC Jr. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconj. Chem. 2002, 13, 453-461.
    • (2002) Bioconj. Chem , vol.13 , pp. 453-461
    • Padilla De Jesus, O.L.1    Ihre, H.R.2    Gagne, L.3    Frechet, J.M.4    Szoka, F.C.5
  • 168
    • 4043103282 scopus 로고    scopus 로고
    • Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery
    • Chen HT, Neerman MF, Parrish AR, Simanek EE. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J. Am. Chem. Soc. 2004, 126, 10044-10048.
    • (2004) J. Am. Chem. Soc , vol.126 , pp. 10044-10048
    • Chen, H.T.1    Neerman, M.F.2    Parrish, A.R.3    Simanek, E.E.4
  • 169
    • 34548532823 scopus 로고    scopus 로고
    • Targeted delivery systems of small interfering RNA by systemic administration
    • Kawakami S, Hashida M. Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab. Pharmacokinet. 2007, 22, 142-151.
    • (2007) Drug Metab. Pharmacokinet , vol.22 , pp. 142-151
    • Kawakami, S.1    Hashida, M.2
  • 171
    • 34248213490 scopus 로고    scopus 로고
    • Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity
    • Hollins AJ, Omidi Y, Benter IF, Akhtar S. Toxicogenomics of drug delivery systems: exploiting delivery system-induced changes in target gene expression to enhance siRNA activity. J. Drug Target. 2007, 15, 83-88.
    • (2007) J. Drug Target , vol.15 , pp. 83-88
    • Hollins, A.J.1    Omidi, Y.2    Benter, I.F.3    Akhtar, S.4
  • 172
    • 0031612974 scopus 로고    scopus 로고
    • The novel lipid delivery system of amphotericin B: Drug profile and relevance to clinical practice
    • Rust DM, Jameson G. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice. Oncol. Nurs. Forum. 1998, 25, 35-48.
    • (1998) Oncol. Nurs. Forum , vol.25 , pp. 35-48
    • Rust, D.M.1    Jameson, G.2
  • 173
  • 175
    • 51049092308 scopus 로고    scopus 로고
    • Factors affecting the clearance and biodistribution of polymeric nanoparticles
    • Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 2008, 5, 505-515.
    • (2008) Mol. Pharm , vol.5 , pp. 505-515
    • Alexis, F.1    Pridgen, E.2    Molnar, L.K.3    Farokhzad, O.C.4
  • 176
    • 84857313332 scopus 로고    scopus 로고
    • influence of formulation variables on the biodistribution of multifunctional block copolymer micelles
    • Fonge H, Huang H, Scollard D, Reilly RM, Allen C. influence of formulation variables on the biodistribution of multifunctional block copolymer micelles. J. Control. Rel. 2012, 157, 366-374.
    • (2012) J. Control. Rel , vol.157 , pp. 366-374
    • Fonge, H.1    Huang, H.2    Scollard, D.3    Reilly, R.M.4    Allen, C.5
  • 178
    • 55949126429 scopus 로고    scopus 로고
    • Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats
    • Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 2008, 3, 703-717.
    • (2008) Nanomedicine , vol.3 , pp. 703-717
    • Longmire, M.1    Choyke, P.L.2    Kobayashi, H.3
  • 179
    • 81255143243 scopus 로고    scopus 로고
    • Improving delivery and effi cacy of nanomedicines in solid tumors: Role of tumor priming
    • Wang J, Lu Z, Gao Y, Wientjes MG, Au JLS. Improving delivery and effi cacy of nanomedicines in solid tumors: role of tumor priming. Nanomedicine 2011, 6, 1605-1620.
    • (2011) Nanomedicine , vol.6 , pp. 1605-1620
    • Wang, J.1    Lu, Z.2    Gao, Y.3    Wientjes, M.G.4    Au, J.L.S.5
  • 180
  • 182
    • 3543022686 scopus 로고    scopus 로고
    • In vivo cancer targeting and imaging with semiconductor quantum dots
    • Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22, 969-976.
    • (2004) Nat. Biotechnol , vol.22 , pp. 969-976
    • Gao, X.1    Cui, Y.2    Levenson, R.M.3    Chung, L.W.4    Nie, S.5
  • 187
    • 68249138692 scopus 로고    scopus 로고
    • Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers
    • Kaminskas LM, Wu Z, Barlow N, Krippner GY, Boyd BJ, Porter CJH. Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers. J. Pharm. Sci. 2009, 98, 3871-3875.
    • (2009) J. Pharm. Sci , vol.98 , pp. 3871-3875
    • Kaminskas, L.M.1    Wu, Z.2    Barlow, N.3    Krippner, G.Y.4    Boyd, B.J.5    Porter, C.J.H.6
  • 189
  • 190
    • 65249178345 scopus 로고    scopus 로고
    • Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery
    • Liu Z, Tabakman S, Welsher K, Dai H. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res. 2009, 2, 85-120.
    • (2009) Nano Res , vol.2 , pp. 85-120
    • Liu, Z.1    Tabakman, S.2    Welsher, K.3    Dai, H.4
  • 191
    • 34249663107 scopus 로고    scopus 로고
    • Translocation and fate of multi-walled carbon nanotubes in vivo
    • Deng X, Jia G, Wang H, Sun H, Wang X, Yang S, Wang T, Liu Y. Translocation and fate of multi-walled carbon nanotubes in vivo. Carbon 2007, 45, 1419-1424.
    • (2007) Carbon , vol.45 , pp. 1419-1424
    • Deng, X.1    Jia, G.2    Wang, H.3    Sun, H.4    Wang, X.5    Yang, S.6    Wang, T.7    Liu, Y.8
  • 193
    • 77649146256 scopus 로고    scopus 로고
    • In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles
    • Kumar R, Roy I, Ohulchanskky TY, Vathy LA, Bergey EJ, Sajjad M, Prasad PN. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4, 699-708.
    • (2010) ACS Nano , vol.4 , pp. 699-708
    • Kumar, R.1    Roy, I.2    Ohulchanskky, T.Y.3    Vathy, L.A.4    Bergey, E.J.5    Sajjad, M.6    Prasad, P.N.7
  • 194
    • 77955613395 scopus 로고    scopus 로고
    • Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals
    • Lu J, Liong M, Li ZX, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6, 1794-1805.
    • (2010) Small , vol.6 , pp. 1794-1805
    • Lu, J.1    Liong, M.2    Li, Z.X.3    Zink, J.I.4    Tamanoi, F.5
  • 196
    • 43449094338 scopus 로고    scopus 로고
    • Is personalized medicine finally arriving ?
    • Allison M. Is personalized medicine finally arriving ? Nat. Biotechnol. 2008, 26, 509-517.
    • (2008) Nat. Biotechnol , vol.26 , pp. 509-517
    • Allison, M.1
  • 199
    • 0037421590 scopus 로고    scopus 로고
    • Pharmacogenomics-drug disposition, drug targets, and side effects
    • Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N. Engl. J. Med. 2003, 348, 538-549.
    • (2003) N. Engl. J. Med , vol.348 , pp. 538-549
    • Evans, W.E.1    McLeod, H.L.2
  • 200
    • 0034305821 scopus 로고    scopus 로고
    • DNA methylation in health and disease
    • Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat. Rev. Genet. 2000, 1, 11-19.
    • (2000) Nat. Rev. Genet , vol.1 , pp. 11-19
    • Robertson, K.D.1    Wolffe, A.P.2
  • 201
    • 0036527775 scopus 로고    scopus 로고
    • Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
    • Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 2002, 1, 287-299.
    • (2002) Nat. Rev. Drug Discov , vol.1 , pp. 287-299
    • Johnstone, R.W.1
  • 202
    • 77951602981 scopus 로고    scopus 로고
    • The past, present and future of pharmacoepigenomics
    • Ingelman-Sundberg M, Gomez A. The past, present and future of pharmacoepigenomics. Pharmacogenomics 2010, 11, 625-627.
    • (2010) Pharmacogenomics , vol.11 , pp. 625-627
    • Ingelman-Sundberg, M.1    Gomez, A.2
  • 203
    • 39649124023 scopus 로고    scopus 로고
    • Array-based DNA diagnostics: Let the revolution begin
    • Beaudet AL, Belmont JW. Array-based DNA diagnostics: let the revolution begin. Annu. Rev. Med. 2008, 59, 113-129.
    • (2008) Annu. Rev. Med , vol.59 , pp. 113-129
    • Beaudet, A.L.1    Belmont, J.W.2
  • 204
    • 67651240453 scopus 로고    scopus 로고
    • Personalized clinical laboratory diagnostics
    • Kewal KJ. Personalized clinical laboratory diagnostics. Adv. Clin. Chem. 2009, 47, 95-119.
    • (2009) Adv. Clin. Chem , vol.47 , pp. 95-119
    • Kewal, K.J.1
  • 205
    • 0032840529 scopus 로고    scopus 로고
    • P-glycoprotein-mediated resistance to chemotherapy in cancer cells: Using recombinant cytosolic domains to establish structure-function relationships
    • Di Pietro A, Dayan G, Conseil G, Steinfels E, Krell T, Trompier D, Baubichon-Cortay H, Jault J. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships. Braz. J. Med. Biol. Res. 1999, 32, 925-939.
    • (1999) Braz. J. Med. Biol. Res , vol.32 , pp. 925-939
    • Di Pietro, A.1    Dayan, G.2    Conseil, G.3    Steinfels, E.4    Krell, T.5    Trompier, D.6    Baubichon-Cortay, H.7    Jault, J.8
  • 208
    • 0344142519 scopus 로고    scopus 로고
    • Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line
    • Minko T, Kopeckova P, Kopecek J. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J. Control. Rel. 1999, 59, 133-148.
    • (1999) J. Control. Rel , vol.59 , pp. 133-148
    • Minko, T.1    Kopeckova, P.2    Kopecek, J.3
  • 209
    • 0032580444 scopus 로고    scopus 로고
    • Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
    • Omelyanenko V, Kopeckova P, Gentry C, Kopecek J. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J. Control. Rel. 1998, 53, 25-37.
    • (1998) J. Control. Rel , vol.53 , pp. 25-37
    • Omelyanenko, V.1    Kopeckova, P.2    Gentry, C.3    Kopecek, J.4
  • 212
    • 0027993707 scopus 로고
    • Effi cacy and safety profi le of gemcitabine in nonsmall-cell lung cancer: A phase II study
    • Abratt RP, Bezwoda WR, Falkson G, Goedhals L, Hacking D, Rugg TA. Effi cacy and safety profi le of gemcitabine in nonsmall-cell lung cancer: a phase II study. J. Clin. Oncol. 1994, 12, 1535-1540.
    • (1994) J. Clin. Oncol , vol.12 , pp. 1535-1540
    • Abratt, R.P.1    Bezwoda, W.R.2    Falkson, G.3    Goedhals, L.4    Hacking, D.5    Rugg, T.A.6
  • 213
    • 0035165047 scopus 로고    scopus 로고
    • Gemcitabine: Progress in the treatment of pancreatic cancer
    • Heinemann V. Gemcitabine: progress in the treatment of pancreatic cancer. Oncology 2001, 60, 8-18.
    • (2001) Oncology , vol.60 , pp. 8-18
    • Heinemann, V.1
  • 214
    • 0036462584 scopus 로고    scopus 로고
    • Determinants of resistance to 2 ' ,2 '-difl uorodeoxycytidine (gemcitabine)
    • Bergman AM, Pinedo HM, Peters GJ. Determinants of resistance to 2 ' ,2 '-difl uorodeoxycytidine (gemcitabine). Drug Resist. Updat. 2002, 5, 19-33.
    • (2002) Drug Resist. Updat , vol.5 , pp. 19-33
    • Bergman, A.M.1    Pinedo, H.M.2    Peters, G.J.3
  • 216
    • 53449098390 scopus 로고    scopus 로고
    • Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fl uoropyrimidine-based chemotherapy: Evidence from 24 studies
    • Qiu LX, Tang QY, Bai JL, Qian XP, Li RT, Liu BR, Zheng MH. Predictive value of thymidylate synthase expression in advanced colorectal cancer patients receiving fl uoropyrimidine-based chemotherapy: evidence from 24 studies. Int. J. Cancer 2008, 123, 2384-2389.
    • (2008) Int. J. Cancer , vol.123 , pp. 2384-2389
    • Qiu, L.X.1    Tang, Q.Y.2    Bai, J.L.3    Qian, X.P.4    Li, R.T.5    Liu, B.R.6    Zheng, M.H.7
  • 219
    • 82255175232 scopus 로고    scopus 로고
    • Squalenoyl gemcitabine nanomedicine overcomes the low effi cacy of gemcitabine therapy in pancreatic cancer
    • Réjiba S, Reddy LH, Bigand C, Parmentier C, Couvreur P, Hajri A. Squalenoyl gemcitabine nanomedicine overcomes the low effi cacy of gemcitabine therapy in pancreatic cancer. Nanomed. Nanotechnol. 2011, 7, 841-849.
    • (2011) Nanomed. Nanotechnol , vol.7 , pp. 841-849
    • Réjiba, S.1    Reddy, L.H.2    Bigand, C.3    Parmentier, C.4    Couvreur, P.5    Hajri, A.6
  • 220
    • 77950160186 scopus 로고    scopus 로고
    • P-Glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells
    • Li RB, Wu R, Zhao L, Wu MH, Yang L, Zou HF. P-Glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. ACS Nano 2010, 4, 1399-1408.
    • (2010) ACS Nano , vol.4 , pp. 1399-1408
    • Li, R.B.1    Wu, R.2    Zhao, L.3    Wu, M.H.4    Yang, L.5    Zou, H.F.6
  • 221
    • 49749101644 scopus 로고    scopus 로고
    • Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifi ers
    • Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifi ers. J. Control. Rel. 2008, 130, 98-106.
    • (2008) J. Control. Rel , vol.130 , pp. 98-106
    • Batrakova, E.V.1    Kabanov, A.V.2
  • 223
    • 0035556313 scopus 로고    scopus 로고
    • Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: Selective energy depletion
    • Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV. Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: selective energy depletion. Br. J. Cancer 2001, 85, 1987-1997.
    • (2001) Br. J. Cancer , vol.85 , pp. 1987-1997
    • Batrakova, E.V.1    Li, S.2    Elmquist, W.F.3    Miller, D.W.4    Alakhov, V.Y.5    Kabanov, A.V.6
  • 224
    • 0141955916 scopus 로고    scopus 로고
    • An essential relationship between ATP depletion and chemosensitizing activity of pluronic((R)) block copolymers
    • Kabanov AV, Batrakova EV, Alakhov VY. An essential relationship between ATP depletion and chemosensitizing activity of pluronic((R)) block copolymers. J. Control. Rel. 2003, 91, 75-83.
    • (2003) J. Control. Rel , vol.91 , pp. 75-83
    • Kabanov, A.V.1    Batrakova, E.V.2    Alakhov, V.Y.3
  • 226
    • 37149036573 scopus 로고    scopus 로고
    • Treatment of neuro-degenerative disorders with radical nanomedicine
    • Singh N, Cohen CA, Rzigalinski BA. Treatment of neuro-degenerative disorders with radical nanomedicine. Ann. NY Acad. Sci. 2007, 1122, 219-230.
    • (2007) Ann. NY Acad. Sci , vol.1122 , pp. 219-230
    • Singh, N.1    Cohen, C.A.2    Rzigalinski, B.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.